Actively Recruiting

Phase 3
Age: 18Years - 45Years
FEMALE
NCT06533098

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Led by Janssen Research & Development, LLC · Updated on 2026-05-08

50

Participants Needed

24

Research Sites

251 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).

CONDITIONS

Official Title

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant with an estimated gestational age between 13 and 18 weeks at the first visit
  • History of at least one prior pregnancy affected by fetal and neonatal alloimmune thrombocytopenia (FNAIT) confirmed by medical records
  • Current pregnancy with maternal anti-HPA-1a and/or anti-HPA-5b antibodies and positive fetal HPA-1a and/or HPA-5b genotype confirmed by fetal DNA in maternal blood
  • Stable health status based on physical exam, medical history, vital signs, ECG, and lab tests at screening
  • Willing to avoid participation in other investigational therapy studies until last follow-up visit for both mother and baby
Not Eligible

You will not qualify if you...

  • Currently pregnant with twins or more (multiple gestations)
  • History of severe preeclampsia in a previous pregnancy
  • History of heart attack, unstable ischemic heart disease, or stroke
  • Known allergies or intolerance to nipocalimab, intravenous immunoglobulin (IVIG), or prednisone
  • Confirmed or suspected immunodeficiency syndrome or family history of congenital or hereditary immunodeficiency unless confirmed absent in participant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 24 locations

1

The University of Alabama at Birmingham

Birmingham, Alabama, United States, 35205

Actively Recruiting

2

UC Davis School of Medicine

Sacramento, California, United States, 95817

Actively Recruiting

3

Childrens Hospital Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Advocate Children's Hospital

Park Ridge, Illinois, United States, 60068

Actively Recruiting

5

University of Iowa Hospital and Clinics

Iowa City, Iowa, United States, 52242

Actively Recruiting

6

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

7

University of Cincinnati

Cincinnati, Ohio, United States, 45267

Actively Recruiting

8

Oregon Health And Science University

Portland, Oregon, United States, 97239

Actively Recruiting

9

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

10

University of Texas Medical Branch

Galveston, Texas, United States, 77555

Actively Recruiting

11

Medizinische Universitaet Graz

Graz, Austria, 8036

Actively Recruiting

12

Medical University Vienna

Vienna, Austria, 1090

Actively Recruiting

13

Universitaetsklinikum Giessen und Marburg GmbH

Giessen, Germany, 35392

Actively Recruiting

14

Medizinische Hochschule Hannover

Hanover, Germany, 30625

Actively Recruiting

15

Universitatsklinikum Jena

Jena, Germany, 07747

Actively Recruiting

16

Universitaetsklinikum Tuebingen

Tübingen, Germany, 72076

Actively Recruiting

17

Leiden University Medical Center

Leiden, Netherlands, 2333 ZA

Actively Recruiting

18

Instytut Centrum Zdrowia Matki Polki

Lodz, Poland, 93 338

Actively Recruiting

19

Instytut Matki i Dziecka

Warsaw, Poland, 01 211

Actively Recruiting

20

Panstwowy Instytut Medyczny MSWiA w Warszawie

Warsaw, Poland, 02 507

Actively Recruiting

21

Birmingham Women's Hospital

Birmingham, United Kingdom, B15 2TG

Actively Recruiting

22

Liverpool Women's NHS Foundation Trust - Liverpool Women's Hospital

Liverpool, United Kingdom, L8 7SS

Actively Recruiting

23

Queen Charlotte's and Chelsea Hospital

London, United Kingdom, W12 0HS

Actively Recruiting

24

John Radcliffe Hospital

Oxford, United Kingdom, OX3 9DU

Actively Recruiting

Loading map...

Research Team

S

Study Contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here